Bolt Biotherapeutics (BOLT) — Financial Flexibility Index
Bolt Biotherapeutics (BOLT) has a Financial Flexibility Index of -0.24x as of December 2025. Free cash flow of $-7.16 Million (operating CF $-7.16 Million minus capex $0.00) represents 0% of total liabilities ($30.24 Million). Check BOLT tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Bolt Biotherapeutics Financial Flexibility Index (2018–2025)
Historical Financial Flexibility Index trend for Bolt Biotherapeutics across 8 annual periods. For the full cash flow conversion analysis, see BOLT cash generation efficiency.
Annual Financial Flexibility Index for Bolt Biotherapeutics (2018–2025)
Year-by-year free cash flow to debt coverage for Bolt Biotherapeutics. Explore BOLT operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.32x | $-39.78 Million | $-39.85 Million | $30.24 Million | ▲ +8.9% |
| 2024 | -1.44x | $-61.25 Million | $-61.29 Million | $42.43 Million | ▲ +2.0% |
| 2023 | -1.47x | $-69.32 Million | $-69.53 Million | $47.04 Million | ▼ -11.3% |
| 2022 | -1.32x | $-74.55 Million | $-76.50 Million | $56.30 Million | ▼ -39.4% |
| 2021 | -0.95x | $-54.73 Million | $-57.07 Million | $57.60 Million | ▼ -226.8% |
| 2020 | -0.29x | $-44.05 Million | $-47.31 Million | $151.49 Million | ▼ -6.1% |
| 2019 | -0.27x | $-25.84 Million | $-26.34 Million | $94.29 Million | ▲ +8.7% |
| 2018 | -0.30x | $-9.58 Million | $-9.87 Million | $31.92 Million | — |